|
Treatment News Keep it SimpleNovember/December 2004
When I started my first anti-HIV drug combination in 1996, it consisted of Crixivan (nine pills a day), Viramune (two pills a day), Epivir (two pills a day) and, if you add on my prophylaxis plus vitamins, I was well into over 20 pills, not to mention having to remember the times of day to take them. We have actually come a long way since then. Most drug combinations being used today only need to be taken twice daily, with several drugs both available now and on the horizon that only need to be taken once a day. More importantly, the number of pills HIV-positive people need to take is getting lower, which is helping to reduce their pill burden and pill fatigue. Some pharmaceutical companies have combined some of their anti-HIV medications into single tablets or capsules, called "combination drugs." With Food & Drug Administration approval this summer of two new combination drugs -- GlaxoSmithKline's Epzicom and Gilead Sciences' Truvada -- there are now four combo drugs available. (The other two are Combivir and Trizivir.) This article highlights the two new combo drugs. What is Epzicom? How is it taken?
What about side effects?
What about drug interaction?
What is Truvada?
How is it taken?
What about side effects?
What about drug interaction?
To get more information on these new anti-HIV drugs and others, please visit our Treatment Resource Center here at AIDS Survival Project, call (404) 874-7926 ext. 13 or 19, or go to these Web sites: As always, KEEP SAFE! This article was provided by AIDS Survival Project. It is a part of the publication Survival News. |
|